东海证券晨会纪要-20251114
Donghai Securities·2025-11-14 02:17

Group 1: Key Recommendations - The report highlights the strong performance of Quick Intelligent (603203), which achieved a revenue of 808 million yuan in the first three quarters of 2025, representing a year-on-year increase of 18.30%, and a net profit of 198 million yuan, up 21.83% year-on-year [5][6] - Lingrui Pharmaceutical (600285) also showed steady growth, with a revenue of 3.041 billion yuan in the first three quarters of 2025, reflecting a year-on-year increase of 10.23%, and a net profit of 651 million yuan, up 13.43% year-on-year [11][12] Group 2: Quick Intelligent (603203) Analysis - The company is capitalizing on the growing demand for precision welding and AOI (Automated Optical Inspection) in the semiconductor packaging equipment sector, with significant orders from major clients [5][6] - The AI terminal market is expanding, with global shipments of generative AI phones exceeding 500 million units by Q3 2025, driving demand for precision welding [5][6] - Quick Intelligent's gross profit margin reached 49.45% in the first three quarters of 2025, an increase of 1.14 percentage points year-on-year, indicating improved profitability [8] Group 3: Lingrui Pharmaceutical (600285) Analysis - The company has successfully integrated Silver Valley Pharmaceutical, contributing significantly to its revenue growth since March 2025 [11][13] - Core products such as the Tongluo Pain Relief Patch are expected to maintain stable growth through enhanced marketing strategies [12][13] - The gross profit margin for Lingrui Pharmaceutical was 81.02% in the first three quarters of 2025, up 6.02 percentage points year-on-year, reflecting strong profitability [12][13]